The pharmaceutical giant Neomedical Industries aims to mass-produce onionhead gamma strain as a medicine. The announcement follows a report from the Interstellar Health Organisation, which details how the new onionhead variant is an effective treatment for many psychological and musculoskeletal conditions. Olwyn Kendrick, CEO of Neomedical Industries, told the... Read more